Approval of Icaridin for PT19



Alexander Brux

phone +49 (0) 2204 83077-23
mobile +49 (0) 151 168 87 532

Mike Bublitz

phone +49 (0) 2204 83077-15
mobile +49 (0) 175 581 72 83

Approval of Icaridin for PT19

As an important component of skin and fabric products as well as of products for horseflies Icaridin is part of the BPR since December 2019. In combination with other substances or single, there is now an authorization requirement for Icaridin. That applies to all suppliers in and out of the EU that place these products on the market (27 EU countries and Switzerland).
The time for creating a dossier takes about 10 to 12 months and should be considered. Tests and studies are required to examine efficacy, analytic, usage, storage and safety, but also toxicological risk for human, pet and environment. Hence, the authorization is estimated to be turned in until 01.02.2022. 

We as BioGenius are your competent test institute and looking forward to assisting you with e. g. required adjustments in formulations (screenings in advance). Beforehand the authorization we offer technical consulting to design suitable registration data sets e. g. time scheduling, calculation and create possible solutions for your unique products. Our combined services include studies in analytics, stability, physico-chemical data and efficacy.

Please don’t hesitate to contact Mike Bublitz or Alexander Brux for further information, to get a calculation without any commitment and of course to put your questions.

Your Competent Test Institute.